 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$145.00 |
$146.47 |
$144.23 |
$145.16 |
398.90K | | 04/19/2024 |
$144.72 |
$146.92 |
$143.50 |
$144.41 |
703.20K | | 04/22/2024 |
$145.21 |
$147.90 |
$143.69 |
$145.79 |
400.00K | | 04/23/2024 |
$147.35 |
$150.27 |
$145.04 |
$146.07 |
543.70K | | 04/24/2024 |
$146.60 |
$147.49 |
$143.52 |
$143.80 |
395.40K |
|
|
| Alnylam Pharmaceuticals is a global biopharmaceutical company developing therapeutics based on ribonucleic acid interference (RNAi). Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO® (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of primary hyperoxaluria type 1 in all age groups. Leqvio (inclisiran) is being developed and commercialized for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. | |
|
Alnylam Pharmaceuticals (ALNY) has the following price history information. Looking back at ALNY historical stock prices for the last five trading days, on April 18, 2024, ALNY opened at $145.00, traded as high as $146.47 and as low as $144.23, and closed at $145.16. Trading volume was a total of 398.90K shares. On April 19, 2024, ALNY opened at $144.72, traded as high as $146.92 and as low as $143.50, and closed at $144.41. Trading volume was a total of 703.20K shares. On April 22, 2024, ALNY opened at $145.21, traded as high as $147.90 and as low as $143.69, and closed at $145.79. Trading volume was a total of 400.00K shares. On April 23, 2024, ALNY opened at $147.35, traded as high as $150.27 and as low as $145.04, and closed at $146.07. Trading volume was a total of 543.70K shares. On April 24, 2024, ALNY opened at $146.60, traded as high as $147.49 and as low as $143.52, and closed at $143.80. Trading volume was a total of 395.40K shares.
ALNY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Alnylam Pharmaceuticals shares, starting with a $10,000 purchase of ALNY, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/28/2014 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$48.87 |
|
| End price/share: |
$143.80 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
194.25% |
|
| Average Annual Total Return: |
11.40% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$29,425.47 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/18/2024 | $145.16 | | 04/19/2024 | $144.41 | | 04/22/2024 | $145.79 | | 04/23/2024 | $146.07 | | 04/24/2024 | $143.80 |
|
|
Free ALNY Email Alerts:
